|1.||Takai, Toshiro: 7 articles (01/2012 - 07/2005)|
|2.||Okumura, Ko: 6 articles (12/2011 - 07/2005)|
|3.||Ogawa, Hideoki: 6 articles (12/2011 - 07/2005)|
|4.||Jacquet, A: 6 articles (01/2010 - 05/2000)|
|5.||Mori, Akio: 4 articles (01/2015 - 01/2009)|
|6.||Suzuki, Kazuya: 4 articles (01/2012 - 01/2008)|
|7.||Takaiwa, Fumio: 4 articles (01/2012 - 01/2008)|
|8.||Yasueda, Hiroshi: 3 articles (01/2015 - 07/2005)|
|9.||Hiroi, Takachika: 3 articles (01/2012 - 01/2009)|
|10.||Kaminuma, Osamu: 3 articles (01/2012 - 01/2009)|
|1.||Asthma (Bronchial Asthma)
09/01/2003 - "As part of a primary prevention of asthma study, we measured the effect of environmental control measures on Der p 1, Fel d 1 and Can f 1 over a 3.5-year period. "
05/01/2000 - "Many of the identified prevalence studies in children showed negative associations between allergen exposure and current asthma, and the weighted averages of the population attributable risks in children were 4% for Der p 1, 11% for Fel d 1, -4% for Bla g 2, and 6% for Can f 1. There was little change in these estimates in studies in which children whose parents had adopted allergen avoidance measures were excluded. "
02/01/1998 - "Twenty mite-allergic children (Skin Prick Test, RAST, mean age 10 years) with asthma and high domestic mite allergen exposure ( > 2 microg Der p 1 + f 1/g mattress dust) were included in our study. "
04/01/1993 - "The effect of ionisers on airborne concentrations of house dust mite allergen Der p I was investigated in a double blind, crossover, placebo controlled trial in the homes of 20 children with allergic asthma. "
11/26/2014 - "The discovery of potent, selective, and reversible inhibitors of the house dust mite peptidase allergen Der p 1: an innovative approach to the treatment of allergic asthma."
07/01/2005 - "The Der p 1 TCR transgenic mice provide a model for investigating the pathophysiological mechanisms of pulmonary inflammation following sensitization by exposure of the airways to allergen and for investigating the mode of action and efficacy of novel immunotherapeutics."
10/01/2002 - "Mice were treated with an intranasal tolerizing regimen of a peptide containing the major T-cell epitope of Der p 1. Delayed hypersensitivity and lung inflammation to challenge with Der p 1 was measured either without further treatment or after sensitization induced by means of the intranasal administration of Der p 1 with a mutated enterotoxin adjuvant. "
11/01/2002 - "The present study was undertaken to determine pathways of Der p 1 (a house dust mite allergen) uptake by human DCs and to compare Der p 1 uptake between DCs from patients with house dust mite allergy and DCs from healthy donors. "
05/01/2009 - "Aggregated forms of Der p 1 could represent hypoallergens suitable for the prevention of mite allergy."
03/01/2009 - "plantarum producing Der p 1 represents a promising vaccine against house dust mite allergy."
01/11/2008 - "Our results indicate that transgenic Der p 1 rice seeds are a safe, potential oral delivery vaccine for the treatment of HDM allergy."
07/01/2007 - "pteronyssinus (Der p 1; referred as Der p hereafter) are common allergy-causing mites found in homes worldwide. "
11/20/2001 - "In previous studies, we developed a murine model of airway inflammation based on the purified, house dust-mite allergen Der p 1 (Dermatophagodies pteronyssinus) as a clinically relevant allergen. "
01/01/2000 - "To develop a mouse model of allergic airway inflammation and hyperresponsiveness based on the use of purified house dust mite allergen (Der p 1) as clinical relevant allergen. "
05/01/1994 - "Until strategies are developed which will significantly reduce Der p 1 levels in the bedding of sensitive individuals, a reduction in ongoing airway inflammation and airway hyperreactivity cannot be expected."
10/01/2011 - "BALB/cJ and C57BL/6J mice were sensitized with the immunodominant allergen from the Dermatophagoides pteronyssinus species of house dust mite (Der p 1), without exogenous adjuvant, and the mice then underwent a single challenge with Der p 1. Allergic inflammation, serum antibody titers, mucous metaplasia, and airway hyperresponsiveness were evaluated 72 hours after airway challenge. "
02/01/2000 - "Effect of current exposure to Der p 1 on asthma symptoms, airway inflammation, and bronchial hyperresponsiveness in mite-allergic asthmatics."
09/01/2010 - "The adjusted odds ratio for current rhinitis increased with 1.20 (95% CI: 1.01, 1.42) per 1 microg/g dust increase in Der p 1 for girls (P=0.037), but not for boys (P=0.91). "
09/01/2010 - "Nevertheless, only increasing levels of Der p 1 and not cat and dog allergens significantly increased the risk of current rhinitis in girls, whereas no significant association was observed for boys."
12/01/1996 - "The concentrations of Der p I and of guanine in HD collected from mattresses were significantly higher in asthmatic subjects than in those with rhinitis (p < 0.05 and < 0.04, respectively). "
10/01/1987 - "During desensitization treatment of patients with perennial rhinitis, levels of IgG4 ab to Der p 1 increased sharply, but there were also increases in the total IgG ab responses so that the percentage contribution of IgG4 was only moderately increased (mean values: before, 29%; after, 36%). "
09/01/2003 - "Exposure to allergens from house dust-mites (Der p 1) and domestic cats (Fel d 1) is associated with symptom severity in atopic subjects with asthma and rhinitis. "
|2.||Dermatophagoides farinae antigen f 1
|3.||Dermatophagoides pteronyssinus antigen p 2
|4.||Immunoglobulin E (IgE)
|5.||Dust (House Dust)
|7.||T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
|8.||Histamine (Histamine Dihydrochloride)
|9.||allergen Bla g 1
|10.||aluminum sulfate (alum)
|2.||Infant Equipment (Crib)